Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy

P. G. Crosignani, C. La Vecchia

Research output: Contribution to journalArticlepeer-review

Abstract

The major indications for the clinical use of oestrogen and progestogen are oral contraception (OC) in young women, and hormonal replacement therapy (HRT) in menopause. Over the past few years, epidemiological data have associated the use of these hormones to different cardiovascular conditions such as myocardial infarction, cerebrovascular disease and venous thromboembolism. This review summarizes the data discussed and the conclusions achieved by the ESHRE Capri Workshop Group, recently published in Human Reproduction.

Original languageEnglish
Pages (from-to)681-687
Number of pages7
JournalHuman Reproduction Update
Volume5
Issue number6
Publication statusPublished - Nov 1999

Keywords

  • Cardiovascular risks
  • Hormone replacement
  • Oestrogen
  • Oral contraception
  • Progestogen

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Fingerprint Dive into the research topics of 'Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy'. Together they form a unique fingerprint.

Cite this